Douglas Wayne Hanto, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 55 | 2018 | 2022 | 4.430 |
Why?
|
| Tissue and Organ Procurement | 25 | 2018 | 850 | 3.150 |
Why?
|
| Kidney Transplantation | 65 | 2016 | 4116 | 2.930 |
Why?
|
| Tissue Donors | 26 | 2018 | 2147 | 1.720 |
Why?
|
| Organ Transplantation | 15 | 2019 | 1071 | 1.610 |
Why?
|
| Living Donors | 15 | 2011 | 569 | 1.560 |
Why?
|
| Lymphoproliferative Disorders | 13 | 2012 | 539 | 1.290 |
Why?
|
| Health Care Rationing | 5 | 2018 | 455 | 1.200 |
Why?
|
| Graft Rejection | 37 | 2013 | 4408 | 1.110 |
Why?
|
| Patient Selection | 10 | 2019 | 4306 | 1.020 |
Why?
|
| Delayed Graft Function | 2 | 2015 | 47 | 0.950 |
Why?
|
| Liver Neoplasms | 12 | 2016 | 4044 | 0.920 |
Why?
|
| Social Support | 6 | 2019 | 2119 | 0.920 |
Why?
|
| Graft Survival | 22 | 2013 | 3767 | 0.860 |
Why?
|
| Transplantation | 3 | 2018 | 228 | 0.850 |
Why?
|
| Waiting Lists | 15 | 2018 | 709 | 0.810 |
Why?
|
| Death | 5 | 2011 | 573 | 0.770 |
Why?
|
| Carcinoma, Hepatocellular | 8 | 2016 | 2060 | 0.750 |
Why?
|
| Immunosuppressive Agents | 18 | 2013 | 4226 | 0.730 |
Why?
|
| Tissue and Organ Harvesting | 6 | 2011 | 364 | 0.730 |
Why?
|
| Psychology | 1 | 2019 | 350 | 0.660 |
Why?
|
| Antilymphocyte Serum | 11 | 2013 | 520 | 0.650 |
Why?
|
| Resource Allocation | 4 | 2018 | 342 | 0.650 |
Why?
|
| Tacrolimus | 6 | 2010 | 717 | 0.610 |
Why?
|
| Cyclosporine | 7 | 2009 | 826 | 0.610 |
Why?
|
| Healthcare Disparities | 6 | 2018 | 2996 | 0.610 |
Why?
|
| Muromonab-CD3 | 8 | 1998 | 107 | 0.610 |
Why?
|
| Transplants | 1 | 2018 | 202 | 0.600 |
Why?
|
| End Stage Liver Disease | 3 | 2018 | 262 | 0.560 |
Why?
|
| Postoperative Complications | 21 | 2013 | 15053 | 0.560 |
Why?
|
| Kidney Failure, Chronic | 10 | 2013 | 2559 | 0.560 |
Why?
|
| Lung Transplantation | 2 | 2013 | 1152 | 0.530 |
Why?
|
| Carbon Monoxide | 3 | 2012 | 543 | 0.490 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2016 | 269 | 0.490 |
Why?
|
| Reperfusion Injury | 4 | 2015 | 1071 | 0.470 |
Why?
|
| Azygos Vein | 1 | 2012 | 20 | 0.470 |
Why?
|
| Goals | 1 | 2017 | 642 | 0.450 |
Why?
|
| Social Adjustment | 2 | 2011 | 639 | 0.430 |
Why?
|
| Job Satisfaction | 1 | 2016 | 555 | 0.430 |
Why?
|
| Cold Ischemia | 1 | 2011 | 59 | 0.420 |
Why?
|
| Acute Kidney Injury | 2 | 2015 | 1896 | 0.410 |
Why?
|
| Geography | 3 | 2017 | 681 | 0.400 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1520 | 0.400 |
Why?
|
| Hepatitis B | 2 | 2012 | 631 | 0.400 |
Why?
|
| Physicians, Family | 1 | 2012 | 357 | 0.380 |
Why?
|
| Workload | 1 | 2016 | 852 | 0.380 |
Why?
|
| Patient Rights | 1 | 2010 | 124 | 0.370 |
Why?
|
| Sirolimus | 5 | 2009 | 1571 | 0.370 |
Why?
|
| Hepatectomy | 7 | 2013 | 561 | 0.370 |
Why?
|
| Abdomen | 1 | 2015 | 1094 | 0.370 |
Why?
|
| Humans | 165 | 2022 | 708843 | 0.360 |
Why?
|
| Herpesvirus 4, Human | 11 | 1995 | 1241 | 0.360 |
Why?
|
| Ethics Committees | 1 | 2008 | 52 | 0.360 |
Why?
|
| Medical Futility | 1 | 2010 | 129 | 0.360 |
Why?
|
| Decision Making | 2 | 2020 | 3802 | 0.360 |
Why?
|
| Creatinine | 3 | 2011 | 1885 | 0.360 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2010 | 170 | 0.360 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 444 | 0.360 |
Why?
|
| Hepatitis B virus | 1 | 2012 | 444 | 0.350 |
Why?
|
| Pancreas Transplantation | 6 | 2009 | 222 | 0.350 |
Why?
|
| Transplantation Immunology | 5 | 2006 | 583 | 0.340 |
Why?
|
| Critical Pathways | 1 | 2011 | 460 | 0.330 |
Why?
|
| Informed Consent | 2 | 2011 | 959 | 0.320 |
Why?
|
| Psychiatry | 1 | 2019 | 1597 | 0.320 |
Why?
|
| Pancreatic Neoplasms | 3 | 2010 | 4930 | 0.300 |
Why?
|
| Family | 4 | 2019 | 3087 | 0.300 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2008 | 265 | 0.300 |
Why?
|
| Health Services Accessibility | 3 | 2019 | 4988 | 0.290 |
Why?
|
| Medical Errors | 1 | 2014 | 1300 | 0.290 |
Why?
|
| Transplantation, Homologous | 16 | 2010 | 4831 | 0.290 |
Why?
|
| Intubation | 1 | 2005 | 139 | 0.280 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 568 | 0.280 |
Why?
|
| Kidney | 9 | 2012 | 6888 | 0.280 |
Why?
|
| Liver Cirrhosis | 5 | 2016 | 1721 | 0.280 |
Why?
|
| Liver | 13 | 2017 | 7622 | 0.270 |
Why?
|
| Health Status Disparities | 3 | 2018 | 1711 | 0.270 |
Why?
|
| Eligibility Determination | 2 | 2018 | 382 | 0.270 |
Why?
|
| Middle Aged | 76 | 2018 | 213752 | 0.260 |
Why?
|
| Physician's Role | 1 | 2012 | 982 | 0.260 |
Why?
|
| Male | 88 | 2020 | 349524 | 0.260 |
Why?
|
| ABO Blood-Group System | 3 | 2003 | 359 | 0.260 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2004 | 30 | 0.260 |
Why?
|
| Biliary Fistula | 1 | 2003 | 37 | 0.250 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 2274 | 0.250 |
Why?
|
| Reoperation | 6 | 2012 | 4159 | 0.240 |
Why?
|
| Female | 94 | 2019 | 375205 | 0.240 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 2176 | 0.240 |
Why?
|
| Public Policy | 2 | 2017 | 543 | 0.230 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 888 | 0.230 |
Why?
|
| Continuity of Patient Care | 2 | 2013 | 1047 | 0.230 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1880 | 0.230 |
Why?
|
| Tumor Virus Infections | 4 | 2013 | 453 | 0.230 |
Why?
|
| Ultrasonics | 1 | 2003 | 211 | 0.230 |
Why?
|
| Adult | 73 | 2018 | 211041 | 0.230 |
Why?
|
| United States | 22 | 2019 | 67165 | 0.220 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2001 | 42 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3153 | 0.220 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3275 | 0.220 |
Why?
|
| Ohio | 5 | 2006 | 335 | 0.210 |
Why?
|
| Liver Diseases | 3 | 2011 | 1246 | 0.210 |
Why?
|
| Histocompatibility Testing | 7 | 2007 | 804 | 0.210 |
Why?
|
| Survival Rate | 10 | 2012 | 13202 | 0.210 |
Why?
|
| Prognosis | 20 | 2018 | 28919 | 0.200 |
Why?
|
| Liver Regeneration | 2 | 2013 | 221 | 0.200 |
Why?
|
| Surgical Instruments | 1 | 2003 | 409 | 0.200 |
Why?
|
| Device Removal | 1 | 2005 | 656 | 0.200 |
Why?
|
| Hepatic Artery | 2 | 2003 | 247 | 0.190 |
Why?
|
| Rimantadine | 1 | 1999 | 12 | 0.190 |
Why?
|
| Bile Ducts | 1 | 2000 | 287 | 0.180 |
Why?
|
| Neurilemmoma | 1 | 2004 | 524 | 0.180 |
Why?
|
| Referral and Consultation | 2 | 2010 | 3436 | 0.180 |
Why?
|
| Addison Disease | 1 | 1999 | 46 | 0.180 |
Why?
|
| Friends | 1 | 2019 | 136 | 0.180 |
Why?
|
| Financial Support | 1 | 2019 | 122 | 0.180 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2000 | 227 | 0.180 |
Why?
|
| Skin Transplantation | 3 | 1992 | 1130 | 0.180 |
Why?
|
| Fluconazole | 1 | 1999 | 150 | 0.180 |
Why?
|
| Hospitals, University | 2 | 2009 | 582 | 0.180 |
Why?
|
| Clinical Competence | 1 | 2014 | 4615 | 0.170 |
Why?
|
| Intestines | 2 | 2005 | 1929 | 0.170 |
Why?
|
| Azathioprine | 5 | 2006 | 345 | 0.170 |
Why?
|
| Herpesviridae Infections | 2 | 1995 | 287 | 0.170 |
Why?
|
| Risk Factors | 19 | 2020 | 69553 | 0.170 |
Why?
|
| Internet | 2 | 2008 | 3074 | 0.170 |
Why?
|
| Transportation | 1 | 2019 | 210 | 0.170 |
Why?
|
| Hepatitis C, Chronic | 2 | 2012 | 1002 | 0.160 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 258 | 0.160 |
Why?
|
| Venous Cutdown | 1 | 1996 | 6 | 0.160 |
Why?
|
| Retrospective Studies | 29 | 2013 | 71483 | 0.160 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1997 | 136 | 0.160 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 1998 | 204 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2016 | 11 | 0.150 |
Why?
|
| Steroids | 2 | 2013 | 880 | 0.150 |
Why?
|
| Accidents | 1 | 2017 | 167 | 0.150 |
Why?
|
| Registries | 5 | 2007 | 7989 | 0.150 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2016 | 84 | 0.150 |
Why?
|
| Lymphocele | 2 | 1996 | 18 | 0.150 |
Why?
|
| Extracorporeal Circulation | 1 | 1996 | 188 | 0.150 |
Why?
|
| Cholangiocarcinoma | 1 | 2001 | 516 | 0.150 |
Why?
|
| Bile Duct Neoplasms | 1 | 2001 | 571 | 0.150 |
Why?
|
| Time Factors | 17 | 2013 | 41038 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2016 | 5556 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2009 | 1938 | 0.140 |
Why?
|
| Short Bowel Syndrome | 1 | 1998 | 296 | 0.140 |
Why?
|
| Follow-Up Studies | 18 | 2018 | 39038 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1996 | 289 | 0.140 |
Why?
|
| B-Lymphocytes | 11 | 1991 | 4861 | 0.140 |
Why?
|
| Multivariate Analysis | 11 | 2013 | 12447 | 0.140 |
Why?
|
| Social Class | 2 | 2018 | 1925 | 0.140 |
Why?
|
| Lymphoma | 9 | 1989 | 1871 | 0.140 |
Why?
|
| Neoplasms | 5 | 2007 | 20172 | 0.140 |
Why?
|
| Housing | 1 | 2019 | 611 | 0.140 |
Why?
|
| Blood Transfusion | 7 | 2012 | 1246 | 0.140 |
Why?
|
| Fatigue | 3 | 2011 | 1450 | 0.140 |
Why?
|
| Adolescent | 32 | 2018 | 84718 | 0.140 |
Why?
|
| Databases, Factual | 3 | 2007 | 7763 | 0.130 |
Why?
|
| Liver Failure | 2 | 2011 | 233 | 0.130 |
Why?
|
| Quality of Life | 8 | 2011 | 11594 | 0.130 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1996 | 278 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 1999 | 710 | 0.130 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1999 | 615 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2003 | 1493 | 0.130 |
Why?
|
| Activities of Daily Living | 3 | 2019 | 2320 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2018 | 2502 | 0.120 |
Why?
|
| Lymphocyte Culture Test, Mixed | 6 | 1995 | 614 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1996 | 538 | 0.120 |
Why?
|
| Alcoholism | 2 | 2013 | 1840 | 0.120 |
Why?
|
| Aged | 32 | 2020 | 161488 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2022 | 1510 | 0.120 |
Why?
|
| Treatment Outcome | 15 | 2013 | 61932 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 2 | 2012 | 382 | 0.120 |
Why?
|
| Survival Analysis | 8 | 2016 | 10507 | 0.120 |
Why?
|
| Isoantigens | 2 | 1995 | 579 | 0.120 |
Why?
|
| Organ Preservation | 1 | 2015 | 274 | 0.120 |
Why?
|
| Peritoneal Neoplasms | 1 | 1998 | 599 | 0.120 |
Why?
|
| Opportunistic Infections | 4 | 2010 | 390 | 0.120 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2013 | 65 | 0.120 |
Why?
|
| Capillary Permeability | 3 | 1986 | 860 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2005 | 2759 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2005 | 3418 | 0.110 |
Why?
|
| Hospital Costs | 1 | 1999 | 982 | 0.110 |
Why?
|
| BK Virus | 1 | 2013 | 136 | 0.110 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2013 | 146 | 0.110 |
Why?
|
| Communicable Diseases | 2 | 1997 | 797 | 0.110 |
Why?
|
| Unemployment | 1 | 2013 | 200 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2015 | 20308 | 0.110 |
Why?
|
| T-Lymphocytes | 9 | 1995 | 10362 | 0.110 |
Why?
|
| Cadaver | 6 | 2009 | 1366 | 0.110 |
Why?
|
| Needs Assessment | 1 | 2018 | 1147 | 0.110 |
Why?
|
| Tissue Transplantation | 1 | 2012 | 134 | 0.110 |
Why?
|
| Immunity, Cellular | 4 | 1986 | 1693 | 0.110 |
Why?
|
| Lymphocytes | 4 | 1983 | 2729 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 6 | 1996 | 753 | 0.110 |
Why?
|
| Risk Assessment | 6 | 2013 | 23284 | 0.110 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2012 | 288 | 0.110 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2012 | 215 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 4810 | 0.100 |
Why?
|
| Polyomavirus Infections | 1 | 2013 | 198 | 0.100 |
Why?
|
| Pregnancy Complications | 2 | 2004 | 2806 | 0.100 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 74 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1995 | 821 | 0.100 |
Why?
|
| Boston | 4 | 2012 | 9402 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6338 | 0.100 |
Why?
|
| Primary Graft Dysfunction | 1 | 2011 | 99 | 0.100 |
Why?
|
| Mice, SCID | 2 | 1995 | 2835 | 0.100 |
Why?
|
| Intraoperative Complications | 3 | 2012 | 1192 | 0.100 |
Why?
|
| Mood Disorders | 3 | 2013 | 1100 | 0.100 |
Why?
|
| Isoantibodies | 1 | 1993 | 660 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2019 | 1969 | 0.090 |
Why?
|
| Israel | 1 | 2011 | 682 | 0.090 |
Why?
|
| Urinalysis | 1 | 2011 | 363 | 0.090 |
Why?
|
| Interleukin-2 | 5 | 2003 | 1936 | 0.090 |
Why?
|
| Regression Analysis | 2 | 2018 | 6451 | 0.090 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1989 | 93 | 0.090 |
Why?
|
| Social Responsibility | 1 | 2012 | 381 | 0.090 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1988 | 39 | 0.090 |
Why?
|
| Cell Death | 2 | 2013 | 1738 | 0.090 |
Why?
|
| Intestinal Volvulus | 1 | 2009 | 55 | 0.090 |
Why?
|
| Mandatory Testing | 1 | 2007 | 22 | 0.090 |
Why?
|
| Spouses | 1 | 2011 | 273 | 0.090 |
Why?
|
| Lupus Nephritis | 1 | 1991 | 331 | 0.080 |
Why?
|
| Young Adult | 8 | 2018 | 55940 | 0.080 |
Why?
|
| Altruism | 1 | 2009 | 206 | 0.080 |
Why?
|
| Biopsy | 5 | 2004 | 6766 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 4 | 2018 | 7487 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2007 | 6530 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 1992 | 1897 | 0.080 |
Why?
|
| Regional Blood Flow | 3 | 1986 | 1580 | 0.080 |
Why?
|
| Directed Tissue Donation | 1 | 2007 | 19 | 0.080 |
Why?
|
| Speech | 1 | 2012 | 485 | 0.080 |
Why?
|
| Ventilator Weaning | 1 | 2008 | 150 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2015 | 1335 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3562 | 0.080 |
Why?
|
| Child | 21 | 2016 | 73636 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 3 | 2009 | 2090 | 0.080 |
Why?
|
| Antiviral Agents | 2 | 1999 | 2768 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 1986 | 718 | 0.080 |
Why?
|
| Endosonography | 1 | 2010 | 573 | 0.080 |
Why?
|
| Lymphocyte Depletion | 1 | 1989 | 638 | 0.080 |
Why?
|
| Lymphokines | 3 | 1986 | 966 | 0.080 |
Why?
|
| Infectious Mononucleosis | 3 | 1988 | 143 | 0.080 |
Why?
|
| Florida | 3 | 2013 | 434 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 1301 | 0.080 |
Why?
|
| Logistic Models | 5 | 2013 | 13468 | 0.070 |
Why?
|
| Surgical Wound Infection | 2 | 2012 | 1490 | 0.070 |
Why?
|
| Incidence | 6 | 2008 | 20320 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2022 | 2837 | 0.070 |
Why?
|
| Anastomosis, Roux-en-Y | 2 | 2009 | 78 | 0.070 |
Why?
|
| Gallbladder Diseases | 1 | 2006 | 124 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 2565 | 0.070 |
Why?
|
| Abdominal Neoplasms | 2 | 1984 | 299 | 0.070 |
Why?
|
| Photomicrography | 1 | 2004 | 75 | 0.070 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2003 | 623 | 0.070 |
Why?
|
| Cyclosporins | 2 | 1988 | 222 | 0.070 |
Why?
|
| Age Factors | 5 | 2011 | 18712 | 0.070 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2005 | 136 | 0.060 |
Why?
|
| Health Policy | 2 | 2013 | 2615 | 0.060 |
Why?
|
| Animals | 23 | 2015 | 170486 | 0.060 |
Why?
|
| Hepatic Veins | 1 | 2003 | 117 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1996 | 605 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1992 | 1924 | 0.060 |
Why?
|
| Costs and Cost Analysis | 3 | 1998 | 1652 | 0.060 |
Why?
|
| Linear Models | 2 | 2011 | 5986 | 0.060 |
Why?
|
| Antifibrinolytic Agents | 1 | 2005 | 248 | 0.060 |
Why?
|
| Glioblastoma | 1 | 1998 | 3344 | 0.060 |
Why?
|
| Algorithms | 1 | 2004 | 13647 | 0.060 |
Why?
|
| HIV Infections | 3 | 2016 | 15538 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3934 | 0.060 |
Why?
|
| Acyclovir | 3 | 1993 | 273 | 0.060 |
Why?
|
| Hemagglutinins | 1 | 2003 | 104 | 0.060 |
Why?
|
| Hypotension | 1 | 2008 | 822 | 0.060 |
Why?
|
| Mice, Inbred Strains | 4 | 1995 | 1922 | 0.060 |
Why?
|
| Lymph Nodes | 7 | 1990 | 3409 | 0.060 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2002 | 134 | 0.060 |
Why?
|
| Ligation | 1 | 2003 | 481 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1990 | 1330 | 0.060 |
Why?
|
| China | 1 | 2008 | 2251 | 0.060 |
Why?
|
| Graft vs Host Reaction | 1 | 1982 | 124 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2012 | 2950 | 0.060 |
Why?
|
| Coronary Thrombosis | 1 | 2005 | 487 | 0.060 |
Why?
|
| Intraoperative Period | 2 | 2007 | 538 | 0.060 |
Why?
|
| Thrombosis | 1 | 1996 | 2840 | 0.060 |
Why?
|
| Plasma Exchange | 1 | 2003 | 153 | 0.060 |
Why?
|
| Drainage | 2 | 2002 | 1131 | 0.060 |
Why?
|
| Antibodies, Viral | 6 | 1990 | 2930 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2013 | 2019 | 0.050 |
Why?
|
| Plasmapheresis | 2 | 1993 | 210 | 0.050 |
Why?
|
| Thoracic Neoplasms | 1 | 1983 | 259 | 0.050 |
Why?
|
| Health Status | 2 | 2013 | 4015 | 0.050 |
Why?
|
| Educational Status | 1 | 2009 | 2278 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 1998 | 8776 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2013 | 9754 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2340 | 0.050 |
Why?
|
| Splenectomy | 1 | 2003 | 405 | 0.050 |
Why?
|
| Jejunostomy | 1 | 2000 | 53 | 0.050 |
Why?
|
| Guanine | 1 | 1982 | 283 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2013 | 6765 | 0.050 |
Why?
|
| Reimbursement Mechanisms | 1 | 2006 | 665 | 0.050 |
Why?
|
| Swine | 1 | 2010 | 5763 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 7089 | 0.050 |
Why?
|
| Immune Tolerance | 3 | 2003 | 2333 | 0.050 |
Why?
|
| Cholangiography | 1 | 2000 | 188 | 0.050 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2000 | 88 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1851 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2011 | 16008 | 0.050 |
Why?
|
| Prednisone | 2 | 1998 | 1556 | 0.050 |
Why?
|
| Mental Health | 1 | 2013 | 2602 | 0.050 |
Why?
|
| Lymphocyte Activation | 5 | 1989 | 5908 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2006 | 1569 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2022 | 745 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2005 | 993 | 0.050 |
Why?
|
| Europe | 1 | 2006 | 3104 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 1981 | 330 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 1995 | 9584 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2124 | 0.050 |
Why?
|
| Caregivers | 1 | 2011 | 1906 | 0.050 |
Why?
|
| Safety | 1 | 2004 | 1224 | 0.050 |
Why?
|
| DNA, Satellite | 1 | 1999 | 67 | 0.050 |
Why?
|
| Immunization, Passive | 3 | 1992 | 633 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1991 | 2100 | 0.050 |
Why?
|
| Recurrence | 3 | 2013 | 8255 | 0.050 |
Why?
|
| Clone Cells | 3 | 1989 | 1767 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 8024 | 0.040 |
Why?
|
| Hypoglycemia | 1 | 2005 | 805 | 0.040 |
Why?
|
| Mice, Inbred DBA | 2 | 1995 | 674 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 1409 | 0.040 |
Why?
|
| Postoperative Care | 3 | 2013 | 1514 | 0.040 |
Why?
|
| Biliary Tract | 1 | 1999 | 139 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6048 | 0.040 |
Why?
|